James M. Hinson
Corporate Officer/Principal en Unicorn Pharma Consulting, Inc. .
Cargos activos de James M. Hinson
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Unicorn Pharma Consulting, Inc. | Corporate Officer/Principal | 06/11/2009 | - |
Historial de carrera de James M. Hinson
Antiguos cargos conocidos de James M. Hinson.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Aldagen, Inc.
 Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | Director Técnico/Científico/I+D | 06/11/2009 | - |
| Corporate Officer/Principal | 06/11/2009 | 06/11/2009 |
Formación de James M. Hinson.
| University of Missouri | Undergraduate Degree |
| Vanderbilt University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Aldagen, Inc.
Aldagen, Inc. Pharmaceuticals: GenericHealth Technology Aldagen, Inc. develops and produces pharmaceutical products. It focuses on developing product candidates to address cardiovascular disease. The firm develops ALD-301 for the treatment of critical limb ischemia; ALD-201 for the treatment of ischemic heart failure; and ALD-401 for the post-acute treatment of ischemic stroke. The company also supplies ALDHbr cells for use in investigator-sponsored clinical studies. Aldagen was founded by Andrew E. Balber, Michael Sherman Colvin, Clay Smith and Nelson Chao in March 2000 and is headquartered in Durham, NC. | Health Technology |
| Unicorn Pharma Consulting, Inc. |
- Bolsa de valores
- Insiders
- James M. Hinson
- Experiencia
